1CHEW G T, GAN S K, WAITS G F. Revisiting the metabolic syndrome [J]. Med J Aust, 2006, 185(8) : 445- 449.
2FORD E S, GILES W H, DIETZ W H. Prevalence of the metabolic syndrome among US adults [ J]. JAMA, 2002, 287 : 356-359.
3LAO X, THOMAS G N, JIANG C, et al. Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study [J]. J Endocrinol Invest, 2006, 29:989-996.
4STRUTHERS A D, MACDONALD T M. Review of aldosterone and angiotensin II, induced target organ damage and prevention [ J ]. Cardiovnsc Res, 2004, 61 (4) : 663-670.
5BOCHUD M, NUSSBERGER J, BOVET P, et al. Plasma aldosterone is independently associated with the metabolic syndrome [J]. Hypertension, 2006, 48(2):239-245.
6GOODFRIEND T L, EGAN B M, KELLEY D E. Aldosterone in obesity [J]. Endocr Res, 1998, 24:789- 796.
7ENGELI S, BOHNKE J, GORZELNIAK K, et al. Weight loss and the renin-angiotensin-aldosterone system [ J]. Hypertension, 2005, 45(3):356-362.
8HIRAMATSU K, YAMADA T, YUKIMURA Y. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients [ J ]. Arch Intern Med, 1981, 141 (12) : 1589- 1593.
9LICATA G, VOLPE M, SCAGLIONE R, et al. Saltregulating hormones in young normotensive obese subjects effects of saline load [J]. Hypertension, 1994, 23 (1 Suppl) : I20-24.
10TORPY D J, BORNSTEIN S R, TAYLOR W, et al. Leptin levels are supressed in primary hyperaldosteronism [ J ]. Horm Metab Res, 1999, 31: 533-536.
8Ganguly A. Primary aldosteronism[J]. N Engl Med, 1998,142:429 - 433.
9Sindelke G, Widimsky J, Hass T, et al. Insulin ction in primary hyperaldosteronism before and after surigical or pharmacological trentment[J]. Exp Clin Endocrinol diabetes, 2000,108 ( 1 ):21 - 22.
